Cargando…
The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial
BACKGROUND: Septic shock is associated with decreased vasopressor responsiveness. Experimental data suggest that central alpha2-agonists like dexmedetomidine (DEX) increase vasopressor responsiveness and reduce catecholamine requirements in septic shock. However, DEX may also cause hypotension and b...
Autores principales: | Cioccari, Luca, Luethi, Nora, Bailey, Michael, Shehabi, Yahya, Howe, Belinda, Messmer, Anna S., Proimos, Helena K., Peck, Leah, Young, Helen, Eastwood, Glenn M., Merz, Tobias M., Takala, Jukka, Jakob, Stephan M., Bellomo, Rinaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367420/ https://www.ncbi.nlm.nih.gov/pubmed/32678054 http://dx.doi.org/10.1186/s13054-020-03115-x |
Ejemplares similares
-
Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial
por: Shehabi, Yahya, et al.
Publicado: (2021) -
Intensive care sedation: the past, present and the future
por: Shehabi, Yahya, et al.
Publicado: (2013) -
Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study
por: Luethi, Nora, et al.
Publicado: (2016) -
The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes
por: Crisman, Marco, et al.
Publicado: (2017) -
Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation
por: Turunen, Heidi, et al.
Publicado: (2015)